2021
DOI: 10.1111/ijd.15910
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic syndrome and hidradenitis suppurativa: epidemiological, molecular, and therapeutic aspects

Abstract: Hidradenitis suppurativa (HS) is a chronic, suppurative condition of the pilosebaceous unit.Patients suffering from HS demonstrate a molecular profile in keeping with a state of systemic inflammation and are often found to fit the criteria for a diagnosis of metabolic syndrome (MetS). In this paper, we review the literature with regards to established data on the prevalence of MetS in HS patients and revise the odds ratio of comorbid disease. Furthermore, we attempt to draw parallels between inflammatory pathw… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 31 publications
(18 citation statements)
references
References 193 publications
0
17
0
1
Order By: Relevance
“…Additionally, variants found by the RNA variant calling may be associated with several metabolic-related disorders, including metabolic syndrome (MetS). MetS concomitant with HS had already been described [ 105 , 106 , 107 ]. Nevertheless, it is not clear if inflammation induced by MetS leads to the initiation of HS or if the systemic inflammation in HS leads to manifestations of MetS [ 106 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Additionally, variants found by the RNA variant calling may be associated with several metabolic-related disorders, including metabolic syndrome (MetS). MetS concomitant with HS had already been described [ 105 , 106 , 107 ]. Nevertheless, it is not clear if inflammation induced by MetS leads to the initiation of HS or if the systemic inflammation in HS leads to manifestations of MetS [ 106 ].…”
Section: Discussionmentioning
confidence: 99%
“…MetS concomitant with HS had already been described [ 105 , 106 , 107 ]. Nevertheless, it is not clear if inflammation induced by MetS leads to the initiation of HS or if the systemic inflammation in HS leads to manifestations of MetS [ 106 ]. MetS is characterized by a combination of clinical conditions including central obesity, hyperglycemia, dyslipidemia, and/or hypertension [ 108 , 109 ].…”
Section: Discussionmentioning
confidence: 99%
“…Although HS has well-documented associations with the metabolic syndrome, which is characterized by systemic inflammation identified at a molecular level [77], the role of adipose tissue in HS has barely been investigated. Obesity is currently shown to represent the primary risk factor in HS at the molecular level [4,28].…”
Section: Hs Pathogenesismentioning
confidence: 99%
“…Metabolic syndrome is present in 32.4% of HS patients [ 42 ]. A recent meta-analysis estimated the pool ratio of metabolic syndrome in HS to be 2.66 (95% CI: 1.90–3.72) [ 43 ]. There is also an association between HS and diabetes mellitus [ 44 , 45 ].…”
Section: Resultsmentioning
confidence: 99%